Search

Your search keyword '"Du, F"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Du, F" Remove constraint Author: "Du, F" Publisher elsevier bv Remove constraint Publisher: elsevier bv
101 results on '"Du, F"'

Search Results

1. Augmentation des lymphocytes T CD4+ et réduction générale des biomarqueurs inflammatoires indépendamment du taux de lymphocytes T CD4+ à l'inclusion pendant 240 semaines de traitement par fostemsavir (FTR) + traitement de fond optimisé (TFO) dans l'étude BRIGHTE

6. 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)

9. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

12. Tumor-selective, chaperone-mediated protein degradation (CHAMP) of the bromodomain transcription factor BRD4

13. 144P Development of a 6-color multiplex crystal digital PCR assay for the simultaneous detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients

14. 741P Phase I results demonstrate highly differentiated safety and PK profile of ADG126, a masked anti-CTLA-4 SAFEbody in patients with advanced solid tumors

16. 177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)

18. Advances and challenges in metal ion separation from water

22. 827P First real-life data on olaparib in 1st line (1stL) maintenance BRCA1/2 mutated epithelial ovarian cancer (EOC) in France: Descriptive analysis of 201 patients (pts) enrolled in the cohort temporary authorization for use (ATUc)

23. 280MO Progression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study

25. 58P Detection of PIK3CA mutations in plasma ctDNA by Crystal Digital PCR for the selection of alpelisib treatment in routine clinical practice in advanced breast cancer patients

27. PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODERATE-TO-HIGH RISK OF RECURRENCE IN CHINA

28. Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the HER2-positive subgroup

35. Combined pathologic‐genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay

40. Energy and system size dependence of ϕ meson production in Cu+Cu and Au+Au collisions

41. Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

44. Hadronization geometry from net-charge angular correlations on momentum subspace (η,ϕ) in Au–Au collisions at sNN=130 GeV

45. Pion, kaon, proton and anti-proton transverse momentum distributions from p+p and d+Au collisions at sNN=200 GeV

Catalog

Books, media, physical & digital resources